Dynavax Technologies

Dynavax Technologies is a commercial-stage biopharmaceutical company focused on developing and commercializing novel vaccines to combat infectious diseases. They leverage proven adjuvant technology, specifically CpG 1018, to enhance the effectiveness of their vaccines. Their flagship product, HEPLISAV-B, is a two-dose adult hepatitis B vaccine approved in the U.S. and EU. Beyond HEPLISAV-B, Dynavax is advancing a broad pipeline of vaccine candidates for other infectious diseases like shingles and pertussis, further demonstrating their commitment to global health protection.

Dynavax's scientific foundation lies in the exploration of Toll-like Receptor (TLR) biology, which plays a crucial role in the innate immune response. Their expertise in TLR9 agonists allows them to target specific immune cells, maximizing the efficacy of their vaccines while minimizing unwanted side effects. Their commitment to quality, integrity, and safety is evident in their strict adherence to ethical and regulatory standards, ensuring they deliver safe and effective vaccines to protect individuals and communities worldwide.

Dynavax Technologies offers flexible work arrangements to its employees, though specifics are not provided. The company highlights its commitment to fostering a rewarding work environment and emphasizes its values-based approach, which suggests a willingness to accommodate employees' needs.

Dynavax Technologies offers a comprehensive benefits package to its employees, fostering a rewarding work environment. They provide a variety of benefits including health insurance, dental and vision coverage, life insurance, short- and long-term disability, paid time off, and a 401(k) plan with a company match. The company is also dedicated to employee well-being and offers additional benefits such as a wellness program, employee assistance program, and flexible work arrangements.

Dynavax Technologies is a commercial-stage biopharmaceutical company focused on developing and commercializing novel vaccines that utilize proven adjuvant technology. Their mission is to protect the world against infectious diseases through the creation of innovative vaccines, aiming to improve global public health.

Dynavax Technologies promotes a culture of collaboration, empowerment, and commitment to doing what is right. They emphasize a dynamic and diverse team environment where individuals are valued and encouraged to make a difference. Their focus on quality, integrity, and safety in vaccine development translates into a work environment that prioritizes innovation and dedication to public health.

Dynavax Technologies is committed to fostering a diverse, equitable, and inclusive work environment. They strive to create a culture where every employee feels valued and where their organization is valued by each employee. Their company values are centered around doing what is right, celebrating individuals, fostering collaboration, empowering employees to make a difference, and embracing challenges. They actively recruit and support diverse talent, promote equal opportunities, and ensure an inclusive environment for all employees.